EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prospective assessment of a quantitative immunofluorescent assay to measure HER2 and TROP2 concentrations on a single tissue biopsy slide

Nay N. N. Chan, Julia Benanto, Liam Scott, Mengni He, C. Jack Robbins, Daniel C. Liebler, Regan Fulton, David L. Rimm

npj Breast Cancer · 12.08.2026

DOI: 10.1038/s41523-026-01034-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift npj Breast Cancer, online erschienen am 12.08.2026. Verfasst von Nay N. N. Chan und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Cancer Institute, Breast Cancer Research Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Cancer Institute
  • Breast Cancer Research Foundation

Zitieren

APA

Chan, N. N. N., Benanto, J., Scott, L., He, M., Robbins, C. J., Liebler, D. C., Fulton, R., & Rimm, D. L. (2026). Prospective assessment of a quantitative immunofluorescent assay to measure HER2 and TROP2 concentrations on a single tissue biopsy slide. npj Breast Cancer. https://doi.org/10.1038/s41523-026-01034-8

Vancouver

Chan NNN, Benanto J, Scott L, He M, Robbins CJ, Liebler DC, et al. Prospective assessment of a quantitative immunofluorescent assay to measure HER2 and TROP2 concentrations on a single tissue biopsy slide. npj Breast Cancer. 2026. doi:10.1038/s41523-026-01034-8

BibTeX
@article{Chan2026,
  author = {Chan, Nay N. N. and Benanto, Julia and Scott, Liam and He, Mengni and Robbins, C. Jack and Liebler, Daniel C. and Fulton, Regan and Rimm, David L.},
  title = {Prospective assessment of a quantitative immunofluorescent assay to measure HER2 and TROP2 concentrations on a single tissue biopsy slide},
  journal = {npj Breast Cancer},
  year = {2026},
  doi = {10.1038/s41523-026-01034-8}
}
Kostenlos starten →